KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,285,000 | +3.0% | 90,792 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,248,000 | -10.6% | 90,792 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,396,000 | -9.8% | 90,792 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,547,000 | +22.4% | 90,792 | -7.0% | 0.00% | 0.0% |
| Q4 2013 | $1,264,000 | +28.2% | 97,592 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $986,000 | +20.7% | 97,592 | -10.8% | 0.00% | 0.0% |
| Q2 2013 | $817,000 | – | 109,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |